Belvedere Trading »

Emergent BioSolutions shares owned by Belvedere Trading

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $31k 12k 2.53
2023-03-31 $126k 12k 10.36

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Put Option (META)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Put Option (GLD)
Microstrategy Cl A New Put Option (MSTR)
Ishares Silver Tr Ishares (SLV)
Coinbase Global Com Cl A (COIN)
Super Micro Computer (SMCI)
Graniteshares Etf Tr 2x Long Nvda Dai Call Option (NVDL)
Etf Opportunities Trust T Rex 2x Long (NVDX)

View all positions for Belvedere Trading

Top funds holding Emergent BioSolutions

BlackRock
Charles Schwab Investment Management
Vanguard Group
Avidity Partners Management
Hotchkis and Wiley Capital Management
Morgan Stanley
Geode Capital Management
Two Sigma Advisers
AQR Capital Management
Two Sigma Investments
Millennium Management
Assenagon Asset Management
Hanna Zanoni
Connor, Clark & Lunn Investment Management
Bridgeway Capital Management

View all funds holding Emergent BioSolutions